Join us at ESCMID 2025 from April 11-15 in Vienna, Austria. Our CEO Kevin Krause, our CSO Alita Miller, and our Head of Chemistry Deidre Johns will be in attendance hearing about the latest breakthroughs in Infectious Diseases R&D, meeting with colleagues and collaborators, and discussing progress on our AI/ML-enabled discovery pipeline of antibacterials focused on MDR gram-negative bacteria and NTM.
Categories
Join us at ESCMID 2025 from April 11-15 in Vienna, Austria
